The HER2-targeted antibody-drug conjugate that Pfizer gained from its Seagen buyout has delivered positive results in a pivotal study among Chinese patients with newly diagnosed bladder cancer ...

The APHINITY study confirmed significant overall survival benefits of a Perjeta-based regimen in HER2-positive early-stage breast cancer, especially for lymph node-positive patients. Ten-year data ...

The Colorado-based biotech is currently evaluating ELVN-002, which is designed to inhibit the HER2 pathway in solid tumors, in a pair of phase 1 trials. One of these studies is looking at ELVN-002 ...

CARACAS, Venezuela (AP) — A 2-year-old girl arrived Wednesday in Caracas to reunite with her mother after she was separated from her parents when they were deported from the U.S. in what ...

“I will leave the $1 million inheritance I received from my parents to my biological daughters.” (Photo subjects are models.) - Getty Images/iStockphoto I’ve been married to my second wife ...

Hoda Kotb is getting candid about parenthood as a single mom. “I’m raising my kids essentially by myself,” Kotb, 60, said on the Wednesday, May 14, episode of the “Making Space” podcast ...

The EMA has started a review of AstraZeneca and Daiichi Sankyo's antibody-drug conjugate (ADC) that could see the drug being used in advanced breast cancer with even lower levels of the HER2 ...

"Am I being a bridezilla by being hurt?" the bride asked Reddit users Kimberlee Speakman is a digital writer at PEOPLE. She has been working at PEOPLE since 2022. She has also worked in broadcast ...

For people with early-stage HER2-positive disease, the APHINITY results validate the sustained benefits of the Perjeta-based regimen,” said Levi Garraway, M.D., Ph.D., Roche's Chief Medical Officer ...

A TikTok content creator has lost her job and had her pilates membership revoked after posting a ‘fat-shaming’ rant that went viral. In a since-deleted clip, Monica from Texas, told her ...

AstraZeneca and Daiichi Sankyo have claimed their seventh FDA approval for Enhertu, getting the go-ahead for the blockbuster drug as a second-line treatment for patients with HER2-low and HER2 ...

"My husband and I were furious," the woman wrote on Reddit Erin Clack is a Staff Editor for PEOPLE. She has been writing about fashion, parenting and pop culture for more than 15 years. Getty A ...